Part 1: Mucormycosis: Prevalence, Risk Factors, Clinical Features and Diagnosis

By sjmartinez • June 2, 2023

Lynch JP 3rd, Fishbein MC, Abtin F, Zhanel GG. Part 1: Mucormycosis: Prevalence, Risk Factors, Clinical Features and Diagnosis. Expert Rev Anti Infect Ther. 2023 Jun 1. doi: 10.1080/14787210.2023.2220964. Epub ahead of print. PMID: 37262298.

Tags: Diagnosis, invasive fungal infections, mold, Mucorales, mucormycosis, Publications, Pulmonary, Critical Care & Sleep Medicine, Rhizopus, Zygomycosis, Zyzomyces

Related Posts

Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials

Lebwohl M, Warren RB, Sofen H, Imafuku S, Paul C, Szepietowski JC, Spelman L, Passeron T, Vritzali E, Napoli A, Kisa RM, Buck A, Banerjee[...]

Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody

Phan T, Zitzmann C, Chew KW, Smith DM, Daar ES, Wohl DA, Eron JJ, Currier JS, Hughes MD, Choudhary MC, Deo R, Li JZ, Ribeiro[...]

“The Patient”

Thure KA. "The Patient". JAMA. 2024 Apr 18. doi: 10.1001/jama.2024.3082. Epub ahead of print. PMID: 38635227.